The complex and varied motion of the cervix–uterus target during external beam
radiotherapy (EBRT) underscores the clinical benefits afforded by adaptive radiotherapy …

Cervix cancer in many countries is declining and screening programmes and immunisation
will reduce the incidence in the next few decades. This guideline attempts to cover …

External beam radiotherapy and brachytherapy are major treatments in the management of
cervical cancer. For early-stage tumours with local risk factors, brachytherapy is a …

Purpose With the results of several recently published clinical trials, this guideline informs on
the use of adjuvant radiation therapy (RT) and systemic therapy in the treatment of …

Purpose To test the hypothesis that intensity modulated radiation therapy (IMRT) reduces
acute hematologic and gastrointestinal (GI) toxicity for patients with locoregionally advanced …

New treatments based on combinations of standard therapeutic modalities and
immunotherapy are of potential use, but require a profound understanding of immune …

Purpose This study reported long-term outcomes of patients with cervical cancer who were
treated with intensity modulated radiation therapy and 3-dimensional (3D) image-guided …

Patients with locally advanced cervical cancer (LACC) treated with chemoradiation often
experience hematologic toxicity (HT), as chemoradiation can induce bone marrow (BM) …

Background: Over the past two decades, there has been significant advancement in the
management of cervical cancer, particularly in the domain of definitive chemoradiotherapy …

For patients with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC),
concurrent chemoradiotherapy improves overall survival as compared to sequential …